Australia's medicines regulator has approved a tablet version of Wegovy, the weight-loss drug, according to The Australian. The decision clears the pill form for the Australian market, and the newspaper reports that it could be on sale before Christmas.
The approval covers Wegovy in oral form rather than the injectable version that has been used for weight management. The Australian's coverage frames the decision as significant for people in Australia seeking treatment for weight loss, and the outlet has published a guide to what the change means for patients.
The clearance was picked up by other Australian outlets, including 7NEWS, which described the regulator's move as approval of the popular weight-loss drug as a pill. The Australian Financial Review reported that weight-loss drug pills are expected to go on sale in Australia by Christmas, matching the timeline in The Australian's account.
The reports do not set out the full conditions of the approval, pricing, or how the pill will be supplied. Those details were not included in the material available, and the coverage so far centres on the regulator's decision and the expected timing of sales.
The TGA's approval makes Australia one of the markets where Wegovy is available in tablet form, based on the reporting. The next thing to watch is the rollout: when stock reaches pharmacies, how the pill is priced, and what guidance accompanies it for people considering treatment. The Australian's explainer on what the decision means for consumers is likely to be the reference point as those details emerge.
